Last updated: October 04, 2026

Application No. 18/854,287

CRYSTALLINE FORM OF LANIFIBRANOR

Non-Final OA

Filed

Oct 04, 2024

Priority

Apr 05, 2022 — EU 22305456.0 +1 more

Examiner

KIFLE, BRUCK

Art Unit

Tech Center

Assignee

Inventiva

OA Round

1 (Non-Final)

Interview Optional

— +15.9% interview lift. Examiner has a relatively high allowance rate (79%); +15.9% interview lift. A written response may suffice.

Based on 1738 resolved cases, 2023–2026

Examiner Intelligence

KIFLE, BRUCK View full profile →

Grants 79% — above average

Career Allowance Rate

1377 granted / 1738 resolved

+19.2% vs TC avg

Strong +16% interview lift

Without

With

+15.9%

Interview Lift

resolved cases with interview

Fast prosecutor

1y 10m

Avg Prosecution

47 currently pending

Career history

1754

Total Applications

across all art units

Statute-Specific Performance

§101

5.9%

-34.1% vs TC avg

§103

12.8%

-27.2% vs TC avg

§102

12.2%

-27.8% vs TC avg

§112

53.6%

+13.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1738 resolved cases

Prosecution Timeline

Oct 04, 2024

Application Filed

Jul 28, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/009,311

Patent 12741962

2,3-DISUBSTITUTED PYRIDO[3,4-B]PYRAZINE-CONTAINING COMPOUNDS AS KINASE INHIBITORS

3y 9m to grant Granted Sep 22, 2026

18/712,505

Patent 12735429

CRYSTAL OF ISOSORBIDE-BIS(TRIMELLITATE ANHYDRIDE) AND METHOD FOR PRODUCING THE SAME

2y 3m to grant Granted Sep 15, 2026

17/908,583

Patent 12715855

FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES

3y 11m to grant Granted Aug 25, 2026

18/285,751

Patent 12708630

COMBINED THERAPY OF 4'-THIO-5-AZA-2'-DEOXYCYTIDINE AND VENETOCLAX

2y 10m to grant Granted Aug 18, 2026

18/679,774

Patent 12703684

MASP-2 INHIBITORS AND METHODS OF USE

2y 2m to grant Granted Aug 11, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

79%

Grant Probability

95%

With Interview (+15.9%)

1y 10m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 1738 resolved cases by this examiner. Grant probability derived from career allowance rate.